Tag results:

Industry & Policy News

LYNPARZA® (olaparib)Plus Abiraterone and Prednisolone Approved in Japan for the Treatment of BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

[Merck] AstraZeneca and Merck announced that LYNPARZA in combination with abiraterone and prednisolone has been approved in Japan for the treatment of adult patients with BRCA-mutated mCRPC.

NIH Awards $3 Million to Wayne State and Henry Ford Health to Impact Research on Liver Disease

[Wayne State University] Dr. Wanqing Liu received a $3 million, five-year award from the National Institute of Environmental Health Sciences of the National Institutes of Health.

Clinical Trial Studying Possible New Treatment Option for Patients with NAFLD

[UC San Diego] According to the National Institutes of Health, approximately 24% of adults in the United States have nonalcoholic fatty liver disease (NAFLD), an umbrella term for a range of liver conditions affecting people who drink little to no alcohol that can lead to cirrhosis, liver cancer, and liver failure.

NICO Awards $75,000 Grant for Advanced Organoid Growth in Brain Tumor Research

[NICO Corporation] Tomas Garzon-Muvdi, MD, MSc, assistant professor of Neurosurgery at Emory University School of Medicine, has been awarded a $75,000 Investigator Initiated Study grant from NICO Corporation.

Biomedical Engineers Michael King, Cynthia Reinhart-King to Join Rice Faculty

[Rice University] Two national leaders in the biomedical engineering field, Michael King and Cynthia Reinhart-King, whose research programs have advanced the understanding and treatment of cancer and other diseases, will join the Rice University faculty next year.

Actimed Therapeutics Secures Additional £4.75M Funding in Series a Extension Round, Almost Doubling Series a Proceeds

[Actimed Therapeutics, Ltd.] The proceeds will be used to fund the continued development of the company and will ensure that preparations remain on track for the global Phase IIb/III IMPACT clinical development program evaluating its lead asset, S-pindolol benzoate in treating cachexia associated with non-small cell lung cancer and colorectal cancer.

Popular